Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | KMO | O15229 | 1/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526231 | 0.82 | MAPT (0.35) | NPC1MAPTRAB9A | |
| SCHEMBL526039 | 0.80 | AR (0.31) | — | |
| SCHEMBL526393 | 0.77 | GCGR (0.37) | GCGRMAPK14NPC1MAPTRAB9A | |
| SCHEMBL526153 | 0.76 | NPC1 (0.36) | GCGRMAPK14NPC1MAPTRAB9A | |
| SCHEMBL532544 | 0.76 | GCGR (0.37) | GCGRMAPK14NPC1MAPTRAB9A | |
| SCHEMBL526884 | 0.75 | GCGR (0.36) | GCGRMAPK14NPC1MAPTRAB9A | |
| SCHEMBL12958383 | 0.72 | RAB9A (0.33) | NPC1MAPTRAB9ARARB | |
| SCHEMBL4078749 | 0.71 | GCGR (0.44) | GCGRKMORARB | |
| SCHEMBL18775537 | 0.68 | — | — | |
| SCHEMBL12369306 | 0.67 | KMO (0.42) | GCGRNPC1MAPTRAB9AKMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012013719-A1 | NEW CYCLOMETALATED COMPLEXES FOR SOLAR CELLS | UNIVERSITA' DEGLI STUDI DI MILANO BICOCCA (IT) | 2012-02-02 | — | — | WO | disclosed |